BREATH TEST FOR DISEASE DETECTION
COVID-19
Breathonix breath test solution provides 60 seconds detection with over 90% accuracy based on Initial clinical trials with National Centre for Infectious Diseases (NCID) of Singapore.
Other Fatal Diseases
Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis.
KEY HIGHLIGHTS
Slingshot 2019 MedTech Winner
Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.
6+ Years of Breath Analysis Research
The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS).
Backed by Reputable Investors
Funded by NUS Enterprise, Origgin and Antler.
COLLABORATION
To the ones who made it possible
JOIN OUR MISSION
Reimagine Diagnostics with Rapid Breath Test for Disease Detection
LATEST UPDATES
